Core Scientific Stock (NASDAQ: CORZ) Drops on Dec. 16, 2025: CoreWeave Data Center Delay, Analyst Forecasts, and What Investors Are Watching Next

Core Scientific Stock (NASDAQ: CORZ) Drops on Dec. 16, 2025: CoreWeave Data Center Delay, Analyst Forecasts, and What Investors Are Watching Next

Core Scientific, Inc. (NASDAQ: CORZ) stock slid sharply on Tuesday, December 16, 2025, as investors digested fresh reporting tied to the company’s fast-growing AI data center business—plus a broader wobble in “AI infrastructure” sentiment that’s been hitting anything connected to
Crescent Energy Company Stock (CRGY) Slides on Dec. 16 After Vital Energy Deal Closes — Latest News, Analyst Forecasts, and What to Watch

Crescent Energy Company Stock (CRGY) Slides on Dec. 16 After Vital Energy Deal Closes — Latest News, Analyst Forecasts, and What to Watch

Crescent Energy Company stock (NYSE: CRGY) fell sharply in Tuesday’s session, December 16, 2025, as investors digested a major milestone: the company’s all-stock acquisition of Vital Energy has officially closed. By late trading, CRGY was around $8.30, down about 7%
RadNet (RDNT) Stock Drops After Hunterbrook Short Report: News, Analyst Forecasts, and What to Watch on Dec. 16, 2025

RadNet (RDNT) Stock Drops After Hunterbrook Short Report: News, Analyst Forecasts, and What to Watch on Dec. 16, 2025

RadNet, Inc. (NASDAQ: RDNT) stock traded sharply lower Tuesday, Dec. 16, 2025, after a newly published short-seller report from Hunterbrook Capital questioned the durability of the company’s artificial intelligence narrative and the way investors interpret several key growth metrics. By
Boston Scientific (BSX) Stock News on Dec. 16, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Boston Scientific (BSX) Stock News on Dec. 16, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Boston Scientific Corporation (NYSE: BSX) is back in the spotlight on Tuesday, December 16, 2025, as the stock trades in the low-$90s—well below its September highs—while Wall Street’s broader view remains notably upbeat on the medical-device leader’s growth outlook. As
IBM Stock (NYSE: IBM) Today: Confluent Deal, AI Momentum, Quantum Roadmap, and Analyst Forecasts on Dec. 16, 2025

IBM Stock (NYSE: IBM) Today: Confluent Deal, AI Momentum, Quantum Roadmap, and Analyst Forecasts on Dec. 16, 2025

International Business Machines Corporation (NYSE: IBM) is back in focus on December 16, 2025 (16.12.2025) as investors weigh a near-term pullback in the shares against a busy pipeline of AI-driven initiatives—most notably IBM’s planned $11 billion acquisition of Confluent and
Go toTop